| Home > In process > Repetitive transcranial magnetic stimulation (rTMS) for improving apraxia in corticobasal syndrome (CBS): an interventional pilot study. |
| Journal Article | DZNE-2026-01203 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Steinkopff
[Darmstadt]
This record in other databases:
Please use a persistent id in citations: doi:10.1007/s00415-026-14268-0
Abstract: Corticobasal syndrome (CBS) is a rare neurodegenerative disorder. We investigated, whether CBS is associated with a GABA deficiency in the cerebral cortex, whether inhibitory repetitive transcranial magnetic stimulation (rTMS) affects cortical GABA+/Cr levels, and whether this improves apraxia.In this bicentric, open-label intervention study, we performed 20 daily sessions of inhibitory rTMS, applied over the clinically more affected parietal cortex. Over a period of 6 months, we examined 18 patients using the Apraxia DATE Testscore Version and, in 15 of these patients, measured cortical GABA+/Cr concentrations in the parietal cortex using proton magnetic resonance spectroscopy (1H-MRS). The secondary endpoints included motor and cognitive performance before and after the intervention.The Intervention revealed an improvement in the DATE Pseudoword subtest (p = 0.025). For the DATE Finger (F) subtest, the analyses showed a significant improvement from pre-intervention to 4 weeks post-intervention (p = < 0.001). Cognitive performance revealed an improvement for the Wordlist Recall in the CERAD-plus battery that remained significant also for the follow-up period (all p < 0.002). The baseline MRS measurements showed a significant deficiency of GABA+/Cr in the parietal cortex on the clinically more severely affected side (p < 0.05) and, post-intervention, a significant increase in GABA+/Cr concentration (p < 0.05). Pearson correlation indicated a marginally significant positive correlation in the DATE-Pseudoword subtest and parietal GABA+/Cr concentration (r = 0.632, p = 0.05).Inhibitory rTMS applied to the clinically more affected parietal cortex in severely affected CBS patients resulted in significant improvements across two apraxia subtests, an improvement of a pre-existing parietal GABA+/Cr deficiency and enhanced cognitive performance.
Keyword(s): Aged (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Middle Aged (MeSH) ; Apraxias: therapy (MeSH) ; Apraxias: etiology (MeSH) ; Apraxias: diagnostic imaging (MeSH) ; Apraxias: metabolism (MeSH) ; Creatine: metabolism (MeSH) ; gamma-Aminobutyric Acid: metabolism (MeSH) ; Neuropsychological Tests (MeSH) ; Parietal Lobe: metabolism (MeSH) ; Parietal Lobe: diagnostic imaging (MeSH) ; Pilot Projects (MeSH) ; Proton Magnetic Resonance Spectroscopy (MeSH) ; Transcranial Magnetic Stimulation: methods (MeSH) ; Treatment Outcome (MeSH) ; Apraxia ; Corticobasal syndrome ; Dementia ; Proton magnetic resonance spectroscopy ; Repetitive transcranial magnetic stimulation ; Creatine ; gamma-Aminobutyric Acid
|
The record appears in these collections: |